ARS Pharmaceuticals, Inc. – NASDAQ:SPRY
ARS Pharmaceuticals stock price today
$13.9
+3.11
+28.82%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
ARS Pharmaceuticals stock price monthly change
-4.93%
month
ARS Pharmaceuticals stock price quarterly change
-4.93%
quarter
ARS Pharmaceuticals stock price yearly change
+91.31%
year
ARS Pharmaceuticals key metrics
Market Cap | 1.07B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.52 |
Revenue | N/A |
EBITDA | -61.99M |
Income | -49.67M |
Revenue Q/Q | -100% |
Revenue Y/Y | -102.97% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeARS Pharmaceuticals stock price history
ARS Pharmaceuticals stock forecast
ARS Pharmaceuticals financial statements
| Jun 2023 | 10K | -17.37M | -173700% |
|---|---|---|---|
| Sep 2023 | 0 | -14.84M | |
| Dec 2023 | -30K | -7.16M | 23893.33% |
| Mar 2024 | 0 | -10.29M |
| Sep 2025 | 23.1M | -4.17M | -18.07% |
|---|---|---|---|
| Oct 2025 | 23.1M | -7.71M | -33.42% |
| Dec 2025 | 16.42M | -20.87M | -127.09% |
| Dec 2025 | 18.6M | -12.54M | -67.44% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 258752000 | 10.2M | 3.94% |
|---|---|---|---|
| Sep 2023 | 248556000 | 11.27M | 4.53% |
| Dec 2023 | 233188000 | 2.42M | 1.04% |
| Mar 2024 | 227583000 | 3.71M | 1.63% |
| Jun 2023 | -16.66M | 44.97M | 2.85M |
|---|---|---|---|
| Sep 2023 | -12.76M | -46.64M | 921K |
| Dec 2023 | -17.40M | 26.03M | 1.80M |
| Mar 2024 | -6.71M | -8.51M | 258K |
ARS Pharmaceuticals alternative data
| Aug 2023 | 27 |
|---|---|
| Sep 2023 | 29 |
| Oct 2023 | 29 |
| Nov 2023 | 29 |
| Dec 2023 | 24 |
| Jan 2024 | 24 |
| Feb 2024 | 24 |
| Mar 2024 | 24 |
| Apr 2024 | 24 |
| May 2024 | 24 |
| Jun 2024 | 24 |
| Jul 2024 | 24 |
ARS Pharmaceuticals other data
55.92%
-44.08%
of SPRY is owned by hedge funds
45
-26
22.34M
-27.78M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 206320 |
| Mar 2024 | 1401299 | 400000 |
| Apr 2024 | 0 | 400000 |
| May 2024 | 0 | 400000 |
| Jun 2024 | 0 | 200000 |
| Aug 2024 | 0 | 1036072 |
| Sep 2024 | 0 | 410000 |
| Oct 2024 | 0 | 412500 |
| Nov 2024 | 0 | 1063270 |
| Dec 2024 | 0 | 1079245 |
ARS Pharmaceuticals Has A Blockbuster Candidate
ARS Pharmaceuticals: Surprise FDA Rejection Presents Cautious Opportunity
ARS Pharmaceuticals Vs. Aquestive Therapeutics; Neffy CRL Creates An Opportunity For Investing In Both
ARS Pharmaceuticals Prepares For Neffy's Anticipated Launch
ARS Pharmaceuticals: Potential Revolution In Allergy Treatment With Neffy
-
What's the price of ARS Pharmaceuticals stock today?
One share of ARS Pharmaceuticals stock can currently be purchased for approximately $13.9.
-
When is ARS Pharmaceuticals's next earnings date?
Unfortunately, ARS Pharmaceuticals's (SPRY) next earnings date is currently unknown.
-
Does ARS Pharmaceuticals pay dividends?
No, ARS Pharmaceuticals does not pay dividends.
-
How much money does ARS Pharmaceuticals make?
ARS Pharmaceuticals has a market capitalization of 1.07B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 97.72% to 30K US dollars.
-
What is ARS Pharmaceuticals's stock symbol?
ARS Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "SPRY".
-
What is ARS Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of ARS Pharmaceuticals?
Shares of ARS Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does ARS Pharmaceuticals have?
As Jul 2024, ARS Pharmaceuticals employs 24 workers.
-
When ARS Pharmaceuticals went public?
ARS Pharmaceuticals, Inc. is publicly traded company for more then 4 years since IPO on 4 Dec 2020.
-
What is ARS Pharmaceuticals's official website?
The official website for ARS Pharmaceuticals is ars-pharma.com.
-
Where are ARS Pharmaceuticals's headquarters?
ARS Pharmaceuticals is headquartered at 3525 Del Mar Heights Road, San Diego, CA.
-
How can i contact ARS Pharmaceuticals?
ARS Pharmaceuticals's mailing address is 3525 Del Mar Heights Road, San Diego, CA and company can be reached via phone at 858 335 1300.
ARS Pharmaceuticals company profile:
ARS Pharmaceuticals, Inc.
ars-pharma.comExchange:
NASDAQ
Full time employees:
24
Industry:
Biotechnology
Sector:
Healthcare
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
3525 Del Mar Heights Road
San Diego, CA 92130
San Diego, CA 92130
CIK: 0001671858
ISIN: US82835W1080
CUSIP: 82835W108
